Lv31
290 积分 2024-05-23 加入
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
2个月前
已完结
Epidemiology of alopecia areata, ophiasis, totalis, and universalis: A systematic review and meta-analysis
2个月前
已完结
A randomized, double-blind, placebo-controlled phase II study to evaluate the efficacy and safety of ivarmacitinib (SHR0302) in adult patients with moderate-to-severe alopecia areata
3个月前
已完结
大数据时代会计信息化的风险与防范分析
4个月前
已完结
皖公网安备34019202002308
